United Patients Group

MARCH 15, 2023

Introduction The medical marijuana industry has been growing rapidly in the United States, and for good reason. The post Can Cannabis Help Patients Titrate Off Other Pharmaceutical Drugs? Remember to consult or discuss this with your doctor or medical professional before starting to titrate off your medications.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

Medical Marijuana Program Connection

FEBRUARY 13, 2024

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates Source link. Read More

Pharmaceutical 64

Pharmaceutical Business 64

Medical Marijuana Program Connection

NOVEMBER 14, 2023

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates Source link. Read More

Pharmaceutical 69

Pharmaceutical Business 69

Medical Marijuana Program Connection

OCTOBER 6, 2023

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) (“Anebulo”), today announced. Read More

Pharmaceutical 64

Pharmaceutical Cannabinoids Business 64

Medical Marijuana Program Connection

FEBRUARY 13, 2024

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.®

Pharmaceutical 49

Pharmaceutical Therapy Conditions Business 49

Medical Marijuana Program Connection

FEBRUARY 19, 2024

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Industry in South Africa 2023” report has been added to ResearchAndMarkets.com’s offering. More than 80% of South African pharmaceutical manufacturing and distribution revenue is from the private sector.

Pharmaceutical 45

Pharmaceutical Business 45

Medical Marijuana Program Connection

DECEMBER 6, 2023

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and. Read More

Clinical Trials 40

Clinical Trials Pharmaceutical Therapy Business 40

Medical Marijuana Program Connection

MAY 12, 2023

–(BUSINESS WIRE)– #pharma–Summary: Virpax Pharmaceuticals to Present at Upcoming CB Tech Watch Seminar Source link. BERWYN, Pa.–(BUSINESS Read More

Pharmaceutical 40

Pharmaceutical Business 40

Medical Marijuana Program Connection

MARCH 2, 2023

MyMD Pharmaceuticals, Inc. MYMD announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational. Read More

Pharmaceutical 52

Pharmaceutical DEA CBD 52

Medical Marijuana Program Connection

JANUARY 31, 2023

–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. Read More

Pharmaceutical 52

Pharmaceutical Business 52

Cannabis Law Report

JANUARY 18, 2023

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East. The move follows seven harvests and extractions in 2022 and the […]

Pharmaceutical 52

Pharmaceutical Medicine THC Extraction 52

Medical Marijuana Program Connection

JANUARY 18, 2023

–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. BERWYN, Pa.–(BUSINESS Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. Read More.

Pharmaceutical 52

Pharmaceutical Business 52

CannaMD

AUGUST 4, 2022

As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.

Patients 135

Patients Therapy Pharmaceutical Marijuana 135

SpeedWeed

SEPTEMBER 3, 2021

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive – Cannabis and Marijuana industry news. The post Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 View original article.

Pharmaceutical 55

Pharmaceutical Business Cannabis Marijuana 55

Medical Marijuana Program Connection

FEBRUARY 11, 2024

… allows the use of medical marijuana. The Pharmaceutical and Healthcare … the harmful effects [of marijuana] that outweigh the purported … conduct of research on medical marijuana, along with the re … emperor Shen Neng prescribed marijuana tea for the treatment … Original Author Link click here to read.

Marijuana 49

Marijuana Pharmaceutical Treatment 49

Veriheal

AUGUST 12, 2021

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

Epilepsy 68

Epilepsy Pharmaceutical Patients Sleep 68

Cannabis Law Report

JANUARY 4, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Unfortunately, this number is expected to increase rapidly with legalized marijuana and access to substances that have five times the THC concentration of regular marijuana,” said Mr. Allen. “We About Anebulo Pharmaceuticals, Inc. and Australia.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

CannaMD

SEPTEMBER 15, 2022

The legalization of marijuana has been linked to serious financial losses in the pharmaceutical industry, according to one new study. A peer-reviewed article published last month in PLOS ONE confirmed many anecdotal reports involving the growing number of people turning to cannabis as an alternative to traditional medications.

Legalization 105

Legalization Pharmaceutical Marijuana Cannabis 105

SpeedWeed

AUGUST 16, 2021

Healthcare & Pharmaceuticals U.S. cannabis firm PharmaCann plans IPO as New York weed legalization lifts demand -sources – Cannabis Business Executive – Cannabis and Marijuana industry news. The post Healthcare & Pharmaceuticals U.S. View original article.

Pharmaceutical 52

Pharmaceutical Business Legalization Cannabis 52

Medical Marijuana Program Connection

FEBRUARY 10, 2023

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid. Read More

Pharmaceutical 40

Pharmaceutical Cannabinoids Business 40

Medical Marijuana Program Connection

JANUARY 2, 2024

–(BUSINESS WIRE)—- $LBPH #DEEs–Longboard Pharmaceuticals, Inc. LA JOLLA, Calif.–(BUSINESS

Pharmaceutical 69

Pharmaceutical Clinical Trials Data Medicine 69

Medical Marijuana Program Connection

DECEMBER 29, 2023

var mantis = mantis || []; mantis.push(['display', 'load', { property: '5bbb53a2bcafb20075d8dc64' }]); BERWYN, Pa.–(BUSINESS –(BUSINESS WIRE)– #pharma–Virpax Announces Results of Special Shareholders Meeting Source link var mantis = mantis || [];…

Pharmaceutical 64

Pharmaceutical Business 64

Cannabis Law Report

NOVEMBER 10, 2019

Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals. Medical Marijuana. Insys Therapeutics. Axim Biotechnologies. Pain Management Device Players: Boston Scientific Crop. Codman &Shurtleff Inc.

Pharmaceutical 45

Pharmaceutical Research and Development Data Business 45

SpeedWeed

APRIL 9, 2021

Although this survey is specifically focused on Texas’ medical marijuana program, it also supports other research showing that cannabis can serve as an effective replacement for pharmaceuticals. The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

CannaMD

NOVEMBER 8, 2021

There is a growing body of both anecdotal evidence and clinical research supporting the benefits of medical marijuana to mitigate the symptoms of Parkinson’s disease. A survey of current […].

Patients 103

Patients Therapy Pharmaceutical Marijuana 103

SpeedWeed

AUGUST 12, 2021

Cannabis Facility Construction Expands into Virginia with Design-Build Project for Dharma Pharmaceuticals – Cannabis Business Executive – Cannabis and Marijuana industry news. skip to Main Content. View original article.

Pharmaceutical 40

Pharmaceutical Business Cannabis Marijuana 40

MMJ Recs

JANUARY 17, 2024

Traditional treatments may not always provide the desired relief, leading many individuals to explore alternative options like medical marijuana. How Medical Marijuana Can Help Arthritis Patients Medical marijuana holds significant promise in providing relief and improving the quality of life for arthritis patients.

Strains 98

Strains Marijuana Indica Microdosing 98

Medical Marijuana Program Connection

JUNE 20, 2023

var mantis = mantis || []; mantis.push(['display', 'load', { property: '5bbb53a2bcafb20075d8dc64' }]); BERWYN, Pa.–(BUSINESS –(BUSINESS WIRE)– #pharma–Virpax Announces CFO Transition Source link var mantis = mantis || []; mantis.push(['recommend', 'load', {…

Pharmaceutical 40

Pharmaceutical Business 40

LifeCannMD

NOVEMBER 24, 2023

#image_title When you decide it is time to get your Medical Marijuana card in Florida , it’s important to be aware of hidden expenses that might not be readily apparent. These hidden fees can accumulate, so it’s essential to factor them in when comparing medical marijuana doctors in Miami.

Marijuana 52

Marijuana Chronic Pain Conditions Strains 52

Medical Marijuana Program Connection

MARCH 20, 2023

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the. Read More

Pharmaceutical 52

Pharmaceutical Data Therapy Business 52

MMJ Recs

APRIL 1, 2024

In recent years, the spotlight on CBD (cannabidiol) within medical marijuana has intensified, with researchers and medical professionals delving deeper into its potential therapeutic benefits. Medical Marijuana and CBD: What You Need to Know When discussing CBD, it’s essential to address its relationship with medical marijuana.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

NORML

NOVEMBER 8, 2019

As a supporter of NORML, I know that you’re aware of the damage that unjust marijuana prohibition continues to inflict across the country, especially on communities of color. Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition.

Access 197

Access Marijuana Treatment Legislation 197

Cannabis Life Network

OCTOBER 8, 2019

. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced […].

Pharmaceutical 40

Pharmaceutical Cannabis Patients Business 40

Cannabis Law Report

JUNE 2, 2021

As states across the nation have responded to an increase in public support for legalized marijuana, including its use for medicinal purposes, Idaho remains one of a handful of states that continues to prohibit any use or possession of marijuana. As of May 2021, a majority of states allow for the medical use of marijuana.

Law 103

Law Marijuana Oil Pharmaceutical 103

Medical Marijuana Program Connection

APRIL 12, 2023

BALTIMORE, MD–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for. Read More

Therapy 52

Therapy Pharmaceutical Clinical Trials Business 52

Medical Marijuana Program Connection

FEBRUARY 28, 2023

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the. Read More

Pharmaceutical 52

Pharmaceutical Therapy Data Business 52

MedicalJane

OCTOBER 28, 2022

A new report published by The Insight Partners shows that the global medical marijuana market is expected to grow at a CAGR of 19.2% The global medical marijuana market size was valued at just $11.70 Increased demand from patients over the past year has helped prop up the medical marijuana industry. Pharmaceuticals.

Marijuana 86

Marijuana Chronic Pain Medicine Pharmaceutical 86